Van Eck Associates Corp Ionis Pharmaceuticals Inc Transaction History
Van Eck Associates Corp
- $64.4 Billion
- Q1 2024
A detailed history of Van Eck Associates Corp transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Van Eck Associates Corp holds 91,101 shares of IONS stock, worth $4.11 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
91,101
Previous 65,831
38.39%
Holding current value
$4.11 Million
Previous $3.33 Million
18.55%
% of portfolio
0.01%
Previous 0.01%
Shares
25 transactions
Others Institutions Holding IONS
# of Institutions
397Shares Held
122MCall Options Held
854KPut Options Held
464K-
Vanguard Group Inc Valley Forge, PA13.4MShares$606 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD13.3MShares$601 Million0.35% of portfolio
-
Black Rock Inc. New York, NY9.77MShares$441 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.3MShares$375 Million5.64% of portfolio
-
Wellington Management Group LLP Boston, MA5.7MShares$257 Million0.04% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $6.41B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...